4 recruiting, 2 completed, 2 withdrawn, 1 terminated. 7 Phase 2, 3 Phase 3, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Recruiting 2, Withdrawn 2, Completed 1, Terminated 1, Unknown 1 |
| Phase 3 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Not applicable | 1 | Recruiting 1 |
Follow this drug Literature Review of EPOCH protocol trials Research Report on EPOCH protocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma Mogamulizumab, DA-EPOCH Protocol, CHOEP protocol - T Cell Lymphoma, T-cell Lymphoma | Phase 2 | Recruiting | Yale University | 22 | 2024-10-09 | 2026-04-14 |
| Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma Etoposide, Cytarabine, PEG-rhG-CSF - Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization | Phase 3 | Recruiting | The Affiliated People's Hospital of Ningbo University | 99 | 2024-08-01 | 2025-12-04 |
| Height Adjusted Versus Standardized Dose of Bupivacaine for Spinal Anesthesia standardized dose, adjusted dose - Regional Anesthesia Morbidity, Cesarean Section Complications | Not applicable | Recruiting | University Hospital, Caen | 250 | 2022-02-23 | 2025-07-25 |
| Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma DA-EPOCH, Rituximab, CHOP - Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 132 | 2019-08-05 | 2026-10-16 |
| Trial of DA-EPOCH Regimen for NHL With HLH DA-EPOCH - NHL With Hemophagocytic Lymphohistiocytosis | Phase 2 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 50 | 2012-06-01 | 2019-02-15 |
| Rituximab and Combination Chemotherapy With or Without Bleomycin Sulfate in Treating Patients With Primary Mediastinal Large B-Cell Lymphoma bleomycin sulfate, rituximab, EPOCH regimen - Lymphoma | Phase 2 | Withdrawn | Ohio State University Comprehensive Cancer Center | 2009-09-01 | 2017-11-30 | |
| Combination Chemotherapy With or Without Etoposide in Treating Older Patients With Non-Hodgkin's Lymphoma CHOP regimen, EPOCH regimen, cyclophosphamide - Lymphoma | Phase 2 / Phase 3 | Terminated | European Organisation for Research and Treatment of Cancer - EORTC | 3 | 2003-03-01 | 2012-09-24 |
| Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma filgrastim, EPOCH regimen, cyclophosphamide - Lymphoma | Phase 3 | Completed | German High-Grade Non-Hodgkin's Lymphoma Study Group | 392 | 2002-04-01 | 2021-05-18 |
| Rituximab Followed by Combination Chemotherapy in Treating Patients With Refractory or Recurrent Non-Hodgkin's Lymphoma rituximab, sargramostim, EPOCH regimen - Lymphoma | Phase 2 | Withdrawn | Medstar Health Research Institute | 1999-09-01 | 2021-10-27 | |
| Treatment and Natural History Study of Lymphomatoid Granulomatosis Interferon, Rituxan and EPOCH, Tumor biopsy - Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid | Phase 2 | Completed | National Cancer Institute (NCI) | 94 | 1995-05-05 | 2025-06-19 |
Lymphoma, Non-Hodgkin (6) · Lymphoma (5) · Lymphoma, Large B-Cell, Diffuse (5) · Lymphoma, Follicular (2) · Lymphoma, T-Cell, Cutaneous (2) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Burkitt Lymphoma (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Epstein-Barr Virus Infections (1) · Lymphohistiocytosis, Hemophagocytic (1) · Lymphoma, Large-Cell, Immunoblastic (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, T-Cell (1) · Lymphomatoid Granulomatosis (1) · Lymphoproliferative Disorders (1)
National Cancer Institute (NCI) (2) · European Organisation for Research and Treatment of Cancer - EORTC (1) · German High-Grade Non-Hodgkin's Lymphoma Study Group (1) · Medstar Health Research Institute (1) · Ohio State University Comprehensive Cancer Center (1) · The Affiliated People's Hospital of Ningbo University (1) · The First Affiliated Hospital with Nanjing Medical University (1) · University Hospital, Caen (1) · Yale University (1)
United States (4) · China (2) · Belgium (1) · France (1) · Germany (1) · Switzerland (1)
Christopher J Melani, M.D. (2) · Kristie A. Blum, MD (1) · Michael G.M. Pfreundschuh, MD (1) · Peipei Ye (1) · Pierre Soubeyran, MD, PhD (1) · Sein Aung, MD (1) · Tarsheen Sethi, MD (1) · Wei Xu, M.D., Ph.D. (1)